The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload.
Digital Pathology, seen as a great potential for productivity enhancement, has not fully delivered on that promise. Some ROI studies have, at best, demonstrated marginally positive return on investment with others demonstrating negative impact on cost post implementation.
We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.
Deciphex plan to be at the forefront of this revolution with cleverly positioned solutions, that deliver on the biggest problems facing pathology today.
Ergonomic workflows integrated with artificial intelligence to optimise pathologist productivity is key in delivery of Deciphex solutions.
Deciphex places the emphasis on triaging out of high volume, low complexity samples, allowing pathologists the time needed to focus on difficult, more challenging content.
Deciphex are focussed on integrating the highest quality proprietary annotated data sets for deep learning development and validation.
Deciphex targets Human Gastrointestinal and Toxicologic Pathology use cases rather than attempting a one size fits all approach.
Donal is an experienced corporate officer in the technology and diagnostics sectors, having 20 years of business leadership experience from start-up through to large corporate enterprise. Donal has considerable M&A experience. He has founded three companies and has senior management experience in Slidepath, Genetix, Leica Microsystems and Leica Biosystems.
Runjan is an experienced Anatomical Pathologist/Histopathologist specialising in GI and pancreatic pathology, who has held chairs of Pathology in South Africa & Glasgow. He was the Program Medical Director & Chief/Professor of Pathology at UHN & University of Toronto. He also was Head of Translational Pathology at the University of Oxford.
Mairin (PhD, MBA) is an experienced COO with >15 years experience in startups and academia. She has considerable experience in operational management, research funding, research programme management and generating IP portfolios. As COO, she also manages all company day to day activities, including defining business strategy, financial, HR and IP.
Mark is an expert in image analysis, machine learning and pattern recognition. He has over 30 years’ experience developing slide scanning and image analysis products for cytogenetics and pathology. Mark has considerable experience in diagnostic product regulation and intellectual property protection, authoring several technology patents.
Andrea is an expert software consultant having 10+ years of experience covering a wide range of technical roles, using different technologies and paradigms. Andrea has delivered cutting-edge cloud solutions in a range of fields such as GIS, Healthcare and Finance. Andrea has worked as senior software architect in companies such as Slidepath, Leica Biosystems and Mastercard.
Mirko is an experienced software architect with 10+ years of engineering practice in fields like aerospace & defence, mobile gaming, wearables and AR solutions. Mirko's focus is on software product and engineering practice, quality and innovation. He has contributed significantly to Digital Pathology imaging solutions working in SlidePath and Leica Biosystems.
Luke has over 15 years of experience in clinical, pharmaceutical and life science with both startups and Fortune 500 corporations. Primarily focused on Digital Pathology and analytics, Luke has led international teams in sales, business development, and marketing. He has a proven track record of exceeding sales goals, novel product launch and expanding market-share in international markets.
Shane is an experienced, results-oriented manager with over 10+ years of experience in Digital Pathology. Shane has worked in regulated multinationals since 2008 and has held multiple management and leadership roles since 2014. Shane believes all problems can ultimately be solved through constant improvement.
Colin has worked in the Digital Pathology sector for 17 years, bringing with him a wealth of experience in the design and delivery of innovative software products. Colin has worked in both dynamic Start-Up and Large Corporate organisations, fulfilling a broad remit of customer-facing roles in Business Development, Sales, Commercial Marketing and Product Management.
Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September.
This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology.
Deciphex, a leading provider of digital pathology and AI-powered services, announced that it has appointed Prof Runjan Chetty as Chief Medical Officer, Luke Benko as Vice President of Global Pathology Services and Chris Polley as Clinical Business Manager UK.
Deciphex is pleased to announce its success, in collaboration with partners Oncomark and UCD, in securing a €3m Government of Ireland, Disruptive Technologies Innovation Fund award to pursue its ongoing research program in cancer prognostics.
To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data.
Invent, DCU, Dublin 9, Ireland